News

In a recent study entitled “Longitudinal PET-MRI reveals β-amyloid deposition and rCBF dynamics and connects vascular amyloidosis to quantitative loss of perfusion” the authors developed a new imaging protocol that allows detection and examination of Alzheimer’s Disease typical beta-amyloid plaques. The study was published in the online issue of…

Researchers at Massachusetts General Hospital (MGH) are looking to flip the molecular switch for inflammatory diseases such as Alzheimer’s to the “off” position. Masao Kaneki, MD, PhD, in the Department of Anesthesia, Critical Care, and Pain Medicine at MGH, discovered that nitric oxide acts on the protein SIRT1, leading…

The Cigna Foundation announced that is awarding a $196,000 World of Difference grant to the Alzheimer’s Association to support the development of a program dedicated to help early stage patients currently diagnosed with Alzheimer’s and other forms of dementia. LiveWell interactive E-Learning Program is meant to be a…

In a recent study entitled “Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer’s disease” the authors report on how people with mild cognitive impairment have higher risk of developing Alzheimer’s, especially if they suffer from anxiety.

A study entitled “A Chaperome Subnetwork Safeguards Proteostasis in Aging and Neurodegenerative Disease” recently published in the journal Cell Reports, identifies a subset of chaperones that protect protein-correct folding in aging brains and neurogenererative diseases, such as Alzheimer’s. In this study, a team of scientists at Proteostasis Therapeutics,…

A novel, potentially disease-modifying treatment for Alzheimer’s disease is set to begin a Phase 2a clinical trial, designed to evaluate efficacy over a time frame of 6 months, across 7 study sites in Australia. ANAVEX 2-73, a pipeline product of Anavex Life Sciences Corp.,…

The National Institutes of Health (NIH) has granted $5.5 million in funding to expand the first large-scale study that aims to identify drugs able to stop or slow the progression of Alzheimer’s disease, which is being conducted by the Washington University School of Medicine in St. Louis. The National…

Dr. Rachelle Doody One of the authorities in Alzheimer’s disease, Dr. Rachelle Doody, is scheduled to give a lecture on the latest updates and developments on the disease, a form of dementia that is estimated to affect at least 5.2 million Americans in 2014…

In a special issue of the Cell Press journal Neuron, experts debated the challenges associated with “translational neuroscience,” and the efforts that should be made to commercialize advances made in the laboratory so that patients can benefit from them. Despite the major advances that science is making in understanding…

Self-reported sleep disturbances may be related to a higher risk of developing Alzheimer’s disease, according to the results of a study conducted at Uppsala University, in Sweden, which were recently published at the Alzheimer’s & Dementia journal. The researchers analyzed data that included 40 years of self-reports, and…